From: Tricuspid valve repair in isolated tricuspid pathology: a 12-year single center experience
Characteristics | Value |
---|---|
Atrial fibrillation | 3 (11.5%) |
Venticular extrasystole | 2 (7.7%) |
Low output syndrome | 1 (3.8%) |
MCS | 1 (3.8%) |
Renal failure | 15 (57.6%) |
Conservative treatment | 10 (38.5%) |
Hemofiltration | 5 (19.2%) |
Respiratory insufficiency | |
Forced respiratpry therapy | 14 (53.8%) |
Re-Intubation | 4 (15.4%) |
Pleural effusion | 19 (73.1%) |
Conservative treatment | 14 (53.8%) |
Drainage | 3 (11.5%) |
Pacemaker-implantation | 1 (3.8%) |
Cerebrovasular accident | 2 (7.7%) |
Stroke | 1 (3.8%) |
Intracerebral bleeding | 1 (3.8%) |
Re-intervention on the tricuspid valve | 0 |
Follow-up, years | median 2.07 (0.3–5) |
Hospital stay, days | median 11 (6.7–16) |
Death during follow-up | 10 (38.5%) |
In-hospital death | 4 (15.4%) |